Prismic Pharmaceuticals


Zachary Dutton, Co-Founder and President, has more than 15 years of experience in the pharmaceutical and healthcare industry and in the commercial development of medical foods. His career has included working with Primus Pharmaceuticals, an innovator in the field of medical foods, where his responsibilities included Business Development, Strategic Planning, and Marketing. Earlier in his career, in addition to managing his own consulting firm, he also managed a nutritional company focused on marketing natural products for maintaining mental health.

Francesco Granata, MD is currently Senior Advisor at Warburg Pincus, a leading private equity firm focused on growth investing. He is an accomplished healthcare executive, with more than 35 years of experience in the international pharmaceutical and biotechnology industries. Before joining Warburg Pincus, Dr. Granata held senior management positions at Pfizer Inc. where he was President of the Northern Europe region; Schering-Plough, where he served as Group Vice President and President for the Europe and Canada region; and most recently at Biogen, Inc., where he was Executive Vice President of Global Commercial Operations, with responsibility for worldwide Commercial Operations and Medical Affairs. Dr. Granata is also Chairman of the Board of Circassia, a UK specialty biopharmaceutical company publicly traded on the London Stock Exchange, and Chairman of BSP Pharmaceuticals, a specialized contract manufacturer focused on oncology and high potency injectables.  He is also a member of the Board of Directors of Italfarmaco, one of Italy’s leading international pharmaceutical groups.

Joseph J. Krivulka is the Founder and current Chairman of Akrimax Pharmaceuticals, a branded pharmaceutical company, and has served in that capacity since its inception in February 2007. He is also the Founder and Chairman of Rouses Point Pharmaceuticals, a generic pharmaceutical products company, as well as the Founder and Chairman of MIST Pharmaceuticals, LLC, a cardiovascular pharmaceutical products company. Prior to this, Mr. Krivulka was the Founder and President of Triax Pharmaceuticals, a dermatology products company, a position he held from November 2004 through the sale of the company to PreCision Dermatology in April 2012. Mr. Krivulka was also a Co-Founder and President of Reliant Pharmaceuticals, LLC, a pharmaceutical company purchased by GSK (GlaxoSmithKline plc). Mr. Krivulka is a former Chief Executive Officer of Bertek, Inc., a subsidiary of Mylan Inc., and Corporate Vice President of Mylan Inc.  Mr. Krivulka is also a member of the Board of Directors of Nektar Therapeutics, a US publicly traded biopharmaceutical company. 

Danilo Casadei Massari, Co-Founder, President Europe and Head of Corporate Development, has extensive experience as a senior pharmaceutical executive and as an entrepreneur. He was President and CEO of Fidia Pharmaceuticals, USA, and Director of International Corporate Development with Fidia Farmaceutici S.p.A. As an entrepreneur he has founded several pharmaceutical companies, including most recently, CM&D Pharma Limited, a company focused on prescription Medical Foods, which was acquired by Nestle Health Science in 2011. 

Peter Moriarty, Co-Founder, Chief Executive Officer and Chairman of the Board of Directors, has extensive pharmaceutical industry and entrepreneurial experience. He was a founder of Shire Pharmaceuticals, and worked for Warner-Lambert and Schering-Plough earlier in his career, including management in a number of overseas locations as well as the United States. Additionally, he has founded a number of other companies focused on increasing pharmaceutical sales force productivity and enhancing pharmaceutical companies’ relationships with their physician customers by the use of remote communication technology.

Guru Ramanathan, Ph.D. is Chief Innovation Officer and Senior Vice President for General Nutrition Corp. (GNC). Prior to GNC, Dr. Ramanathan was a senior director for Royal Numico's U.S. subsidiaries, and earlier in his career was Medical Director for the U.S. subsidiary of Scotia Pharmaceuticals. Dr. Ramanathan is a Dental Surgeon by profession. 
 
Jith Veeravalli is the Chairman of the Gencor group of companies (Gencor Nutrients, Gencor Pacific, Gencor Middle East, and Gencor Pacific Organics), a worldwide provider of active pharmaceutical ingredients. Prior to founding Gencor in 1999, Mr. Veeravalli was the CEO of General Packaging Industries, and earlier in his career a Project Economist with the World Health Organization in Botswana. 

Board of Directors